Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenerative Medical Technology (RMTG) Interest Expenses (2018 - 2025)

Historic Interest Expenses for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $3.5 million.

  • Regenerative Medical Technology's Interest Expenses rose 28549.8% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 327.45%. This contributed to the annual value of $5.6 million for FY2024, which is 1309.29% down from last year.
  • Per Regenerative Medical Technology's latest filing, its Interest Expenses stood at $3.5 million for Q3 2025, which was up 28549.8% from $1.1 million recorded in Q2 2025.
  • Regenerative Medical Technology's Interest Expenses' 5-year high stood at $3.5 million during Q3 2025, with a 5-year trough of $319228.0 in Q1 2021.
  • In the last 5 years, Regenerative Medical Technology's Interest Expenses had a median value of $1.1 million in 2021 and averaged $1.3 million.
  • Per our database at Business Quant, Regenerative Medical Technology's Interest Expenses tumbled by 6118.34% in 2021 and then skyrocketed by 28549.8% in 2025.
  • Regenerative Medical Technology's Interest Expenses (Quarter) stood at $1.1 million in 2021, then grew by 11.13% to $1.2 million in 2022, then surged by 38.03% to $1.6 million in 2023, then tumbled by 37.56% to $1.0 million in 2024, then soared by 242.36% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $1.1 million for Q2 2025, and $893850.0 during Q1 2025.